Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome

Bray Denard; Andrea Pavia-Jimenez; Weina Chen; Noelle S. Williams; Harris Naina; Robert Collins; James Brugarolas; Jin Ye

doi:10.1371/journal.pone.0129233

Loading metrics

Open Access

Peer-reviewed

Research Article

Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome

Bray Denard,

Affiliation Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯
Andrea Pavia-Jimenez,

Affiliations Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America, Department of Developmental Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯
Weina Chen,

Affiliation Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯
Noelle S. Williams,

Affiliation Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯
Harris Naina,

Affiliation Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯
Robert Collins,

Affiliation Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯
James Brugarolas,

Affiliations Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America, Department of Developmental Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America, Kidney Cancer Program in Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯
Jin Ye

* E-mail: jin.ye@utsouthwestern.edu

Affiliation Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America
⨯

Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome

Bray Denard,
Andrea Pavia-Jimenez,
Weina Chen,
Noelle S. Williams,
Harris Naina,
Robert Collins,
James Brugarolas,
Jin Ye

Published: June 25, 2015
https://doi.org/10.1371/journal.pone.0129233

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Small cell lung cancer
Is the Subject Area "Small cell lung cancer" applicable to this article?

Thanks for your feedback.
Renal cell carcinoma
Is the Subject Area "Renal cell carcinoma" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.